Hutchmed shares slide as recalls cancer treatment Tazverik
9th Mar 2026 10:49
(Alliance News) - Hutchmed China Ltd on Monday saw its shares fall after reporting the withdrawal of a cancer medication which it licenses from Ipsen SA. Read More
| Price | 209.00p on 16-03-2026 at 18:55:13 |
|---|---|
| Change | -1.00p -0.48% |
| Buy | 218.00p |
| Sell | 209.00p |
| Last Trade: | Sell 1.00 at 209.45p |
| Day's Volume: | 4,248 |
| Last Close: | 209.00p |
| Open: | 209.00p |
| ISIN: | KYG4672N1198 |
| Day's Range | 209.00p - 209.00p |
| 52wk Range: | 187.50p - 292.00p |
| Market Capitalisation: | £1.80b |
| VWAP: | 209.32484p |
| Shares in Issue: | 859.52m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 1 | 209.45p | Ordinary |
15:55:10 - 16-Mar-26 |
| Buy* | 1 | 213.95p | Ordinary |
15:25:23 - 16-Mar-26 |
| Sell* | 3 | 209.90p | Ordinary |
15:17:31 - 16-Mar-26 |
| Buy* | 4 | 213.95p | Ordinary |
15:17:31 - 16-Mar-26 |
| Sell* | 2,000 | 209.45p | Ordinary |
12:12:14 - 16-Mar-26 |
| Sell* | 800 | 209.45p | Ordinary |
09:18:51 - 16-Mar-26 |
| Sell* | 40 | 210.40p | Ordinary |
08:42:08 - 16-Mar-26 |
| Unknown* | 0 | 210.00p | SI Trade |
08:00:16 - 16-Mar-26 |
| Buy* | 4 | 218.00p | SI Trade |
08:00:16 - 16-Mar-26 |
| Unknown* | 0 | 218.00p | SI Trade |
08:00:16 - 16-Mar-26 |
Hutchmed (HCM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 9th Mar 2026 9:30 am | RNS | Update on Licensed Oncology Product in China |
| 6th Mar 2026 8:30 am | RNS | Directorate change |
| 5th Mar 2026 1:00 pm | RNS-R | Publication of Form 20-F |
| 5th Mar 2026 11:00 am | RNS | 2025 Full Year Results and Business Updates |
| 4th Mar 2026 8:30 am | RNS-R | HUTCHMED Initiates Global Trial of ATTC Candidate |
| 6th Feb 2026 8:30 am | RNS | HUTCHMED to Announce 2025 Final Results |